Css LLC Bio Xcel Therapeutics, Inc. Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $130,923 - $209,313	11,700 Added 187.2%	17,950 $212,000
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $204,556 - $488,172	-22,653 Reduced 78.38%	6,250 $82,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $36,360 - $55,339	-2,424 Reduced 7.74%	28,903 $604,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $112,672 - $196,504	5,600 Added 21.77%	31,327 $637,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $108,019 - $145,127	4,531 Added 21.38%	25,727 $781,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $447,524 - $597,982	-15,400 Reduced 42.08%	21,196 $616,000
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $899,832 - $1.49 Million	23,049 Added 170.14%	36,596 $1.58 Million
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $117,019 - $155,934	-2,756 Reduced 16.9%	13,547 $626,000
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $455,757 - $786,740	12,173 Added 294.75%	16,303 $707,000
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $72,770 - $242,472	4,130 New	4,130 $219,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.